Trial Profile
To compare the ultrasound findings between patients in rheumatoid arthritis treated with Golimumumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2017
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 01 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism